COMMUNIQUÉS West-GlobeNewswire

Eckert & Ziegler BEBIG SA and Eckert & Ziegler Strahlen- und Medizintechnik AG will propose to their shareholders the merger of the two companies
11/10/2018
Press release Inside and regulated information 11 October 2018, 19:30 (CEST) Eckert & Ziegler BEBIG SA and Eckert & Ziegler Strahlen- und Medizintechnik AG will propose to their shareholders the merger of the [...]
Eckert & Ziegler BEBIG SA et Eckert & Ziegler Strahlen- und Medizintechnik AG vont proposer à leurs actionnaires la fusion entre les deux sociétés
11/10/2018
Communiqué de presse Information privilégiée et réglementée 11 Octobre 2018, 19:30 (CEST) Eckert & Ziegler BEBIG SA et Eckert & Ziegler Strahlen- und Medizintechnik AG vont proposer à leurs actionnaires la [...]
Texas Companies and Universities Bring World’s Largest Algae Technology Conference to The Woodlands
11/10/2018
Event showcases breakthrough algae innovations in human health, agriculture, wastewater and fuel HOUSTON, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Texas-based companies and universities are working with the Algae Biomass [...]
CTD Holdings to Host Webinar on its Phase I Clinical Trial for Niemann-Pick Disease Type C
11/10/2018
ALACHUA, Fla., Oct. 11, 2018 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease, today announced a one- [...]
Pediapharm Announces Closing of Subscription Receipt Offering for Total Gross Proceeds of $62 Million
11/10/2018
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAW. MONTREAL, Oct. 11, [...]
Virbac : revenue grew by +5.5% at constant exchange rates at the end of September 2018
11/10/2018
Revenue grew by +5.5% at constant exchange rates at the end of September 2018 KEY FIGURES Revenue Year-to-date September 2018 €634.3 million Total growth +0.7% Growth at constant exchange rates +5.5% Growth at constant [...]
Virbac : chiffre d'affaires en croissance de +5,5% à taux de change constants à fin septembre 2018
11/10/2018
Chiffre d'affaires en croissance de +5,5% à taux de change constants à fin septembre 2018 CHIFFRES CLÉS Chiffre d'affaires Neuf mois 2018 634,3 m€ Évolution globale +0,7% Croissance à taux de change constants +5,5% [...]
TG Therapeutics, Inc. Announces Final Phase 2 Multiple Sclerosis Data Presentation at the 34th Congress of ECTRIMS
11/10/2018
Annualized Relapse Rate (ARR) of 0.07 observed for all patients on Phase 2 trial ECTRIMS data review conference call to be held today, October 11, 2018, 19:30 CEST/1:30pm ET NEW YORK, Oct. 11, 2018 (GLOBE NEWSWIRE) -- [...]
Zynerba Pharmaceuticals to Present at the 2018 BIO Investor Forum
11/10/2018
DEVON, Pa., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric [...]
Corporate Update To Shareholders: Preparatory Work For Regulatory Filings On Track
11/10/2018
HASBROUCK HEIGHTS, N.J., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Following many shareholder enquiries in recent weeks Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is pleased to provide shareholders with a brief update on [...]
OncBioMune Advancing ProscaVax Towards Second Phase 2 Clinical Trial for Prostate Cancer with Protocol Submission to FDA
11/10/2018
BATON ROUGE, La., Oct. 11, 2018 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary [...]
Vital Therapies Provides Strategic Update
11/10/2018
SAN DIEGO, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq: VTL), a biotherapeutic company that has been developing ELAD®, a cell-based therapy targeting the treatment of liver failure, today announced [...]
MedAustron selected C-RAD Catalyst PT
11/10/2018
MedAustron selected C-RAD Catalyst PT C-RAD announced today that it signed a purchasing agreement with MedAustron – the first Ion-therapy treatment site in Austria. The agreement entails the acquisition of C-RAD’s most [...]
ClearCorrect and Dental Monitoring connect doctors and patients with mobile clear aligner monitoring
11/10/2018
ROUND ROCK, Texas, Oct. 11, 2018 (GLOBE NEWSWIRE) -- ClearCorrect , LLC, a leading manufacturer of clear aligners, is joining forces with Dental Monitoring SAS to empower doctors to monitor the progress of orthodontic [...]
SeaSpine Prices Public Offering of Common Stock
11/10/2018
CARLSBAD, Calif., Oct. 11, 2018 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE) (“SeaSpine” or the “Company”), a global medical technology company focused on surgical solutions for the treatment of [...]
Carequality Seeks Community Input As It Expands Governance to FHIR
11/10/2018
VIENNA, Va., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Carequality , a national-level, interoperability trusted exchange framework , is actively seeking input from the healthcare community as it adds support for FHIR-based [...]
ADMA Biologics Provides Regulatory Update for BIVIGAM®
11/10/2018
RAMSEY, N.J. and BOCA RATON, Fla., Oct. 11, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical and specialty immunoglobulin [...]
Teladoc Health Announces Availability of Best Doctors Oncology Insight in Canada
11/10/2018
Now available to Sun Life Financial clients, Oncology Insight provides patients facing cancer access to the world’s leading oncologists, backed by recommended treatment options from IBM Watson for Oncology TORONTO, Oct [...]
Cerner to Release Third Quarter 2018 Earnings Results October 25
11/10/2018
KANSAS CITY, Mo., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq: CERN) today announced it will release its third quarter 2018 earnings results after the market closes Thursday, Oct. 25. Following the [...]

Pages